David Owen

Oxford Gene Technology Ltd. develops arrays used in genomics research. It engages in providing services to the pharmaceutical and other sectors in making DNA arrays known as in-situ synthesis of oligonucleotide robes. The company was founded by Edwin Southern in 1995 and is headquartered in Begbroke, the United Kingdom.

Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom.

Compound Photonics Ltd. designs and manufactures light modulator products. It offers light engines, laser and radio frequency components. The company was founded by Jerry Woodall and Jonathan A. Sachs in 2008 and is headquartered in Phoenix, AZ.

Part of The European Molecular Biology Laboratory, EMBL Enterprise Management Technology Transfer GmbH is an alternative investment manager. The company is based in Heidelberg, Germany. The German company was founded in 1999. The CEO is Gabor M. Lamm.

Abcellute was founded in September 2001 as a spinout from the school of biosciences, Cardiff University. Abcellute's core technology is proprietary media Sure Tran -that enables the extended use of fresh cells with out the need for cryopreservation. The company's vision is to achieve global adoption of its SureTran cell transport technology by providing the research community with enhanced, fresh-cell systems. These will maximize the utilization of this often scarce resource and provide products that are much more convenient to use than current fresh-cell systems. This will deliver benefits to biomedical researchers in key areas such as pre-clinical drug evaluation and regenerative medicine.

Sepal Pharma SA develops cancer therapies. The company was founded on July 20, 2004 and is headquartered in Paris, France.

Diagnostics for the Real World (Europe) Ltd. develops diagnostic tests. The firm develops cutting-edge technologies and diagnostic assays for deployment in resource poor countries primarily through patient sample testing at the point of care or near the patient. Its signal amplification technologies offer rapid and reliable tests for Chlamydia, Hepatitis and HIV. The company was founded by Helen Lee in 2002 and is headquartered in Little Chesterford, the United Kingdom.